Cargando…
Interest of colchicine for the treatment of cystic fibrosis patients. Preliminary report.
Cystic fibrosis (CF) lung disease is characterized by persistent inflammation. Antiinflammatory drugs, such as corticosteroids and ibuprofen, have proved to slow the decline of pulmonary function although their use is limited because of frequent adverse events. We hypothesized that colchicine could...
Autores principales: | Sermet-Gaudelus, I, Stoven, V, Annereau, J P, Witko-Sarsat, V, Reinert, P, Guyot, M, Descamps-Latscha, B, Lallemand, J Y, Lenoir, G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781779/ https://www.ncbi.nlm.nih.gov/pubmed/10704084 |
Ejemplares similares
-
Inflammation and CFTR: might neutrophils be the key in cystic fibrosis?
por: Witko-Sarsat, V, et al.
Publicado: (1999) -
Myeloperoxidase Promoter Polymorphism −463G
Is Associated With More Severe Clinical Expression of Cystic
Fibrosis Pulmonary Disease
por: Reynolds, Wanda F., et al.
Publicado: (2006) -
Neutrophil-derived Oxidants and Proteinases as Immunomodulatory Mediators in Inflammation
por: Witko-Sarsat, V., et al.
Publicado: (1994) -
Immunomodulatory role of phagocyte-derived chloramines involving lymphocyte glutathione
por: Witko-Sarsat, Véronique, et al.
Publicado: (1993) -
Correction to: In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study
por: Sermet-Gaudelus, I., et al.
Publicado: (2018)